Skip to main content

David Masao Ota, MD

Publications

Lesurf, R., O. L. Griffith, M. Griffith, J. Hundal, L. Trani, M. A. Watson, R. Aft, et al. “Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.” Ann Oncol 28, no. 5 (May 1, 2017): 1070–77. https://doi.org/10.1093/annonc/mdx048.

Full Text

Ellis, Matthew J., Vera J. Suman, Jeremy Hoog, Rodrigo Goncalves, Souzan Sanati, Chad J. Creighton, Katherine DeSchryver, et al. “Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).” J Clin Oncol 35, no. 10 (April 1, 2017): 1061–69. https://doi.org/10.1200/JCO.2016.69.4406.

Full Text

McDonald, Sandra A., Elaine R. Mardis, David Ota, Mark A. Watson, John D. Pfeifer, and Jonathan M. Green. “Comprehensive genomic studies: emerging regulatory, strategic, and quality assurance challenges for biorepositories.” Am J Clin Pathol 138, no. 1 (July 2012): 31–41. https://doi.org/10.1309/AJCPXBA69LNSCVMH.

Full Text

McCarter, Martin D., Cristina R. Antonescu, Karla V. Ballman, Robert G. Maki, Peter W. T. Pisters, George D. Demetri, Charles D. Blanke, et al. “Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence.” J Am Coll Surg 215, no. 1 (July 2012): 53–59. https://doi.org/10.1016/j.jamcollsurg.2012.05.008.

Full Text

Ellis, Matthew J., Li Ding, Dong Shen, Jingqin Luo, Vera J. Suman, John W. Wallis, Brian A. Van Tine, et al. “Whole-genome analysis informs breast cancer response to aromatase inhibition.” Nature 486, no. 7403 (June 10, 2012): 353–60. https://doi.org/10.1038/nature11143.

Full Text

Ellis, Matthew James, Li Ding, Dong Shen, Jingqin Luo, Vera J. Suman, Reece J. Goiffon, John W. Wallis, et al. “Whole genome sequencing to characterize luminal-type breast cancer.” In Journal of Clinical Oncology, Vol. 30. AMER SOC CLINICAL ONCOLOGY, 2012.

Scholars@Duke

Diehl, Kathleen M., Erin M. Green, Armin Weinberg, Wayne A. Frederick, Dennis R. Holmes, Bettye Green, Arden Morris, et al. “Features associated with successful recruitment of diverse patients onto cancer clinical trials: report from the American College of Surgeons Oncology Group.” Ann Surg Oncol 18, no. 13 (December 2011): 3544–50. https://doi.org/10.1245/s10434-011-1818-9.

Full Text

Chan, E., Q. Shi, J. Garcia-Aguilar, B. G. Wolff, C. S. Johnson, B. Sanders, X. Carrero, M. C. Posner, D. M. Ota, and C. R. Thomas. “Chemoradiation (CRT) Safety Analysis of ACOSOG Z6041: A Phase II Trial of Neoadjuvant (NEO) CRT followed by Local Excision (LE) in uT2 Rectal Cancer (RC).” In International Journal of Radiation Oncology*Biology*Physics, 78:S53–54. Elsevier BV, 2010. https://doi.org/10.1016/j.ijrobp.2010.07.159.

Full Text

Ota, David M., Heidi Nelson, and Armando Giuliano. “Node biopsy vs. full lymph node dissection for breast cancer.” Bull Am Coll Surg, October 2010.

Scholars@Duke

Pages